INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)

Condition:   Respiratory Papillomatosis Interventions:   Drug: INO-3107;   Device: CELLECTRA™ 2000 Sponsor:   Inovio Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials